ARTICLE | Clinical News
Sofosbuvir/velpatasvir: Phase III data
May 9, 2016 7:00 AM UTC
Top-line data from the open-label, U.S. Phase III ASTRAL-5 trial in 104 patients with chronic HCV genotype 1-6 and HIV co-infection showed that once-daily 400/100 mg oral sofosbuvir/velpatasvir for 12...